Consistently in vivo, KRAS (labeled with Cy3) in BMECs (labeled with anti-CD31-FITC) of mice treated with TGFβ1 prior infection was downregulated, in contrast to those left untreated (Fig. 3B). Here, KRAS is linked to infection.